Parkman Healthcare Partners LLC Atreca, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$4.91 - $9.07 $494,083 - $912,695
-100,628 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$7.82 - $13.8 $401,674 - $708,837
-51,365 Reduced 33.79%
100,628 $857,000
Q1 2021

May 14, 2021
BUY
$13.0 - $19.34 $334,555 - $497,714
25,735 Added 20.38%
151,993 $2.33 Million
Q4 2020

Feb 12, 2021
BUY
$13.03 - $17.09 $1.19 Million - $1.56 Million
91,258 Added 260.74%
126,258 $2.04 Million
Q3 2020

Nov 13, 2020
BUY
$12.67 - $23.19 $443,450 - $811,650
35,000 New
35,000 $489,000

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email